PCS6422 and capecitabine

Drug identity checked against registry records

Also recorded as eniluracil

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerNCT06568692Processa PharmaceuticalsPhase 2Terminated2026-07-29Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.